{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hérédité multifactorielle : Questions médicales les plus fréquentes",
"headline": "Hérédité multifactorielle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hérédité multifactorielle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-27",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hérédité multifactorielle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Modes de transmission héréditaire",
"url": "https://questionsmedicales.fr/mesh/D040582",
"about": {
"@type": "MedicalCondition",
"name": "Modes de transmission héréditaire",
"code": {
"@type": "MedicalCode",
"code": "D040582",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.420"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hérédité multifactorielle",
"alternateName": "Multifactorial Inheritance",
"code": {
"@type": "MedicalCode",
"code": "D020412",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zexuan Zhu",
"url": "https://questionsmedicales.fr/author/Zexuan%20Zhu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Muhammad Umar Nasir",
"url": "https://questionsmedicales.fr/author/Muhammad%20Umar%20Nasir",
"affiliation": {
"@type": "Organization",
"name": "Riphah School of Computing & Innovation, Faculty of Computing, Riphah International University Lahore Campus, Lahore 54000, Pakistan."
}
},
{
"@type": "Person",
"name": "Mohammed Gollapalli",
"url": "https://questionsmedicales.fr/author/Mohammed%20Gollapalli",
"affiliation": {
"@type": "Organization",
"name": "Department of Computer Information Systems, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia."
}
},
{
"@type": "Person",
"name": "Muhammad Adnan Khan",
"url": "https://questionsmedicales.fr/author/Muhammad%20Adnan%20Khan",
"affiliation": {
"@type": "Organization",
"name": "Pattern Recognition and Machine Learning Lab, Department of Software, Gachon University, Seongnam, Gyeonggido 13120, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Kord M Kober",
"url": "https://questionsmedicales.fr/author/Kord%20M%20Kober",
"affiliation": {
"@type": "Organization",
"name": "University of California, San Francisco."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Universal HIV screening in the emergency department: an interrupted time series analysis.",
"datePublished": "2022-06-22",
"url": "https://questionsmedicales.fr/article/35730396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003282"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trauma team leader and early mortality: An interrupted time series analysis.",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36244124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajem.2022.09.048"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suicide among soldiers and social contagion effects: An interrupted time-series analysis.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36746079",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.socscimed.2023.115747"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of the economic recession on suicide mortality in Brazil: interrupted time series analysis.",
"datePublished": "2022-06-10",
"url": "https://questionsmedicales.fr/article/35703676",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2021-0778"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis.",
"datePublished": "2024-07-04",
"url": "https://questionsmedicales.fr/article/39219771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2471/BLT.23.290330"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Modes de transmission héréditaire",
"item": "https://questionsmedicales.fr/mesh/D040582"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hérédité multifactorielle",
"item": "https://questionsmedicales.fr/mesh/D020412"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hérédité multifactorielle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hérédité multifactorielle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hérédité multifactorielle",
"description": "Comment diagnostiquer une maladie multifactorielle ?\nQuels tests sont utilisés pour le diagnostic ?\nLes antécédents familiaux sont-ils importants ?\nPeut-on identifier des marqueurs génétiques ?\nQuel rôle joue la génétique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Interrupted+Time+Series+Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hérédité multifactorielle",
"description": "Quels sont les symptômes courants des maladies multifactorielle ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nLes symptômes sont-ils similaires à d'autres maladies ?\nPeut-on avoir des symptômes sans antécédents familiaux ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Interrupted+Time+Series+Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hérédité multifactorielle",
"description": "Comment prévenir les maladies multifactorielle ?\nL'éducation génétique aide-t-elle à la prévention ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nLes changements de mode de vie sont-ils efficaces ?\nLes vaccinations jouent-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Interrupted+Time+Series+Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hérédité multifactorielle",
"description": "Quels traitements sont disponibles pour les maladies multifactorielle ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des traitements préventifs ?\nLes traitements sont-ils efficaces à long terme ?\nLes traitements peuvent-ils avoir des effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Interrupted+Time+Series+Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hérédité multifactorielle",
"description": "Quelles complications peuvent survenir ?\nLes complications sont-elles évitables ?\nLes complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être gérées ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Interrupted+Time+Series+Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hérédité multifactorielle",
"description": "Quels sont les principaux facteurs de risque ?\nL'alimentation influence-t-elle le risque ?\nLe stress est-il un facteur de risque ?\nL'exercice physique joue-t-il un rôle ?\nLes facteurs environnementaux sont-ils significatifs ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Interrupted+Time+Series+Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie multifactorielle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique familial, les tests génétiques et l'évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques, des analyses sanguines et des examens cliniques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à évaluer le risque et à orienter le diagnostic des maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des marqueurs génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains marqueurs génétiques peuvent indiquer une prédisposition à des maladies spécifiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La génétique aide à comprendre les facteurs héréditaires contribuant à la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies multifactorielle ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon la maladie, mais peuvent inclure fatigue, douleurs et anomalies physiques."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains symptômes peuvent se manifester à l'enfance, tandis que d'autres apparaissent à l'âge adulte."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à d'autres maladies ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se chevaucher avec d'autres conditions, rendant le diagnostic complexe."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans antécédents familiaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent également déclencher des symptômes sans antécédents héréditaires."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies multifactorielle ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, des dépistages réguliers et la gestion des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'éducation génétique aide-t-elle à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques génétiques peut aider les individus à prendre des décisions éclairées."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests peuvent identifier les personnes à risque et orienter les mesures préventives."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, adopter un mode de vie sain peut réduire le risque de développer certaines maladies."
}
},
{
"@type": "Question",
"name": "Les vaccinations jouent-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies multifactorielle ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des thérapies physiques et des interventions chirurgicales selon la maladie."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des caractéristiques génétiques et des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions préventives peuvent réduire le risque, comme des changements de mode de vie et des dépistages."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon la maladie et le traitement, nécessitant un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils avoir des effets secondaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comme tout traitement, il peut y avoir des effets secondaires qui doivent être surveillés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications varient selon la maladie, mais peuvent inclure des problèmes chroniques et des handicaps."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles évitables ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et une gestion appropriée."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses complications peuvent être gérées avec des traitements appropriés et un suivi."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies multifactorielle peuvent entraîner des complications à long terme nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, l'environnement, le mode de vie et des conditions médicales préexistantes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut augmenter le risque de certaines maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à l'apparition de maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "L'exercice physique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque d'exercice peut augmenter le risque de développer certaines maladies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils significatifs ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des polluants peut augmenter le risque de maladies multifactorielle."
}
}
]
}
]
}
Department of Computer Information Systems, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Division of Plant Sciences and Interdisciplinary Plant Group, College of Agriculture, Food and Natural Resources, Christopher S. Bond Life Sciences Center, University of Missouri, 1201 Rollins Street, Columbia, MO, 65201, USA.
Pediatric Neurology Unit, Department of Pediatrics, Navarra Health Service Hospital, Irunlarrea 4, 310620 Pamplona, Spain; Navarrabiomed-Miguel Servet Research Foundation, Pamplona, Spain.
Neurometabolic Diseases Laboratory, IDIBELL, Hospital Duran i Reynals, Gran Via 199, 08908, L'Hospitalet de Llobregat, Barcelona, Spain; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain; Center for Biomedical Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain. Electronic address: apujol@idibell.cat.
School of Information Technology, Skyline University College, Sharjah 1797, UAE.
Network and Communication Technology Lab, Center for Cyber Security, Faculty of Information Science and Technology, Universiti Kebangsaan, Malaysia 43600, Malaysia.
Department of Computer Science, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Department of Computer Science (CS), College of Computer Science and Information Technology (CCSIT), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Department of Computer, Deanship of Preparatory Year and Supporting Studies, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
We performed a calendar-matched, 12-month, before (November 27, 2017 to November 26, 2018) and after (November 27, 2018 to November 26, 2019) study, to assess the utility of an emergency department-ba...
The trauma team leader (TTL) is a "model" of a specifically dedicated team leader in the emergency department (ED), but its benefits are uncertain. The primary objective was to assess the impact of th...
Major trauma admissions (Injury Severity Score (ISS)≥12) in 3 Canadian Level-1 trauma centres were included from 2003 to 2017. The TTL program was implemented in centre 1 in 2005. An interrupted time ...
TTL implementation was not associated with changes in mortality or admission delays from the ED. Future studies should assess the potential impact of TTL programs on other patient-centred outcomes usi...
Suicide has become an increasingly concerning problem among soldiers in recent years. Previous research has hypothesized that media-related social contagion effects, termed "Werther effects," may cont...
An interrupted time-series analysis, relying on annual military suicide rates between 1873 and 1910, indicated a significant increase in the suicide rate the year of Rudolf's death, a pattern consiste...
Although we are very careful when interpreting causal effects with our historical data, we discuss the latter finding by questioning whether a change in military culture, that is, the establishment of...
to analyze trends in suicide rates in Brazil in the period before and after the start of the economic recession....
interrupted time series research using national suicide data recorded in the period between 2012 and 2017 with socioeconomic subgroups analyses. Quasi-Poisson regression model was employed to analyze ...
there was an abrupt increase in the risk of suicide after economic recession in the population with less education (12.5%; RR = 1.125; 95%CI: 1.027; 1.232) and in the South Region (17.7%; 1.044; 1.328...
the Brazilian economic recession caused different effects on suicide rates, considering social strata, which requires health strategies and policies that are sensitive to the most vulnerable populatio...
To assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on protests by health workers....
We conducted an interrupted time series analysis of data from 159 countries for 2 years before and after the World Health Organization classified COVID-19 as a pandemic in March 2020, thus between 201...
In total, there were 18 322 health worker protests in 133 countries between 2018 and 2022. The number of weekly health worker protests globally increased by 47% (30.1/63.5), an increase of 30.1 protes...
The pandemic increased the overall level of health worker protests globally as well as the number of countries experiencing such protests. These protests highlight discontent in the health workforce. ...
We are sometimes forced to use the Interrupted Time Series (ITS) design as an identification strategy for potential policy change, such as when we only have a single treated unit and cannot obtain com...
We hypothesized that children with Down syndrome who were born after the implementation of first-trimester combined screening for trisomy 13, 18, and 21 and a second-trimester ultrasound scan in Denma...
A nationwide register-based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biomet...
We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z-scores of birthweight and head circumference increased over time before screening, bu...
After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non-severe congen...
In Australia, the available published literature demonstrated a spike in dispensed prescription medicines after the onset of the COVID-19 pandemic that subsequently returned to expected levels. Smokin...
Australia's universal health-care system provides access to government-subsidised medicines via the Pharmaceutical Benefits Scheme and records of dispensed medicines are publicly available on a nation...
After an initial spike in medicines at the onset of the pandemic, the monthly rate of prescriptions dispensed for varenicline was predominantly within predicted ranges, while that of NRT patches was p...
There has been a differential change in the number of subsidised smoking cessation medicines supplied in Australia since the COVID-19 pandemic, with varenicline prescriptions largely within, and NRT p...
To evaluate the seasonality of acute bronchiolitis in Brazil during the 2020-2022 season and compare it with the previous seasons....
Data from the incidence of hospitalizations due to acute bronchiolitis in infants <1 year of age were obtained from the Department of Informatics of the Brazilian Public Health database for the period...
Compared to the pre-COVID-19 period, the incidence of hospitalizations related to acute bronchiolitis decreased by 97% during non-pharmacological interventions (March 2020 - August 2021) but increased...
This study underscores the significant influence of COVID-19 interventions on acute bronchiolitis hospitalizations in Brazil. The restoration of a seasonal pattern in 2022 highlights the interplay bet...
The aim of this study is to reveal the impact of the COVID-19 pandemic, which constitutes an extraordinary situation, on the habits of emergency health service use. The data of the study consist of em...